Compare XNCR & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | PBI |
|---|---|---|
| Founded | 1997 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2013 | 1994 |
| Metric | XNCR | PBI |
|---|---|---|
| Price | $29.82 | $16.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $41.58 | $19.72 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 11-13-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 2.43% |
| EPS Growth | 65.36 | ★ 175.00 |
| EPS | N/A | ★ 1.12 |
| Revenue | $125,576,000.00 | ★ $1,892,629,000.00 |
| Revenue This Year | $18.52 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.96 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $8.95 |
| 52 Week High | $33.60 | $19.07 |
| Indicator | XNCR | PBI |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 38.19 |
| Support Level | $22.80 | $15.89 |
| Resistance Level | $30.61 | $16.56 |
| Average True Range (ATR) | 1.71 | 0.48 |
| MACD | 0.59 | -0.07 |
| Stochastic Oscillator | 61.74 | 17.99 |
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.